Press release
Next-Generation Oncology Solution Market Trends, Opportunities and Forecast 2023-2029| Illumina, PerkinElmer, Thermo Fisher Scientific
Leading players of the global Next-Generation Oncology Solution market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Next-Generation Oncology Solution market. Furthermore, the report offers two separate market forecasts - one for the production side and another for the consumption side of the global Next-Generation Oncology Solution market. It also provides useful recommendations for new as well as established players of the global Next-Generation Oncology Solution market.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/5582829/Global-Next-Generation-Oncology-Solution-Market-Insights-Forecast-to-2029
Key Players Mentioned in the Global Next-Generation Oncology Solution Market Research Report: Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Paige, GE Healthcare, Varian, Brainlab, Qiagen, Hologic, Pacific Biosciences, AstraZeneca, BGI Group
Our market analysts are experts in deeply segmenting the global Next-Generation Oncology Solution market and thoroughly evaluating the growth potential of each and every segment studied in the report. Right at the beginning of the research study, the segments are compared on the basis of consumption and growth rate for a review period of nine years. The segmentation study included in the report offers a brilliant analysis of the global Next-Generation Oncology Solution market, taking into consideration the market potential of different segments studied. It assists market participants to focus on high-growth areas of the global Next-Generation Oncology Solution market and plan powerful business tactics to secure a position of strength in the industry.
Global Next-Generation Oncology Solution Market by Type: Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy), Software, Others
Global Next-Generation Oncology Solution Market by Application: Hospitals, Diagnostic Imaging Centers, Others
Next-Generation Oncology Solution market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Next-Generation Oncology Solution market. The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.
Important Sections from TOC
Report Overview: It provides a quick look at product and application segments of the global Next-Generation Oncology Solution market, major players, study objectives, years considered, and research scope.
Executive Summary: It provides an overview of the entire market research study and quick information on the global Next-Generation Oncology Solution market.
Marketing Strategy Analysis: It includes thorough analysis of downstream customers, distributors, and sales channels.
Market Influence Factors Analysis: It includes Porter's Five Forces Analysis of the global Next-Generation Oncology Solution market and an in-depth study on market risks, challenges, opportunities, and other dynamics.
Size Forecasts: The Next-Generation Oncology Solution report has analysed the industry based on the value and volume over the projected period. Other important parameters including price, capacity, cost, revenue, gross margin, sales revenue, and production are also looked into
Future Prospects: The Next-Generation Oncology Solution report sheds light on the lucrative business prospects that may prove promising for the players to make future investment
Trend Analysis: The readers will gain an insight into the upcoming trends and developments that may take place in the coming future
Market Size by Product and Application: It includes accurate market size forecasts for different product and application segments of the global Next-Generation Oncology Solution market.
Production by Regions: This section throws light on import and export scenarios, leading players, production value growth rate, and production growth rate of all regions included in the Next-Generation Oncology Solution report.
Competitive Analysis: The Next-Generation Oncology Solution report here discusses about the key strategic initiatives considered by the key players to sustain their hold. This analysis will surely help the competitors in planning their activities ahead.
Cost and Price Analysis: The authors of the report have taken into account almost all factors influencing the costing and pricing scenarios of the global Next-Generation Oncology Solution market.
Recommendations: Players can use the recommendations provided in the report to increase their competitiveness in the global Next-Generation Oncology Solution market.
Appendix: It covers a disclaimer, author details, data sources, research approach, and research methodology.
Request for customization in Report: https://www.qyresearch.com/customize-request/form/5582829/Global-Next-Generation-Oncology-Solution-Market-Insights-Forecast-to-2029
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Oncology Solution Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global Next-Generation Oncology Solution Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostic Imaging Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Oncology Solution Market Perspective (2018-2029)
2.2 Global Next-Generation Oncology Solution Growth Trends by Region
2.2.1 Next-Generation Oncology Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Next-Generation Oncology Solution Historic Market Size by Region (2018-2023)
2.2.3 Next-Generation Oncology Solution Forecasted Market Size by Region (2024-2029)
2.3 Next-Generation Oncology Solution Market Dynamics
2.3.1 Next-Generation Oncology Solution Industry Trends
2.3.2 Next-Generation Oncology Solution Market Drivers
2.3.3 Next-Generation Oncology Solution Market Challenges
2.3.4 Next-Generation Oncology Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Next-Generation Oncology Solution by Players
3.1.1 Global Next-Generation Oncology Solution Revenue by Players (2018-2023)
3.1.2 Global Next-Generation Oncology Solution Revenue Market Share by Players (2018-2023)
3.2 Global Next-Generation Oncology Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Next-Generation Oncology Solution, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Next-Generation Oncology Solution Market Concentration Ratio
3.4.1 Global Next-Generation Oncology Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Oncology Solution Revenue in 2022
3.5 Global Key Players of Next-Generation Oncology Solution Head office and Area Served
3.6 Global Key Players of Next-Generation Oncology Solution, Product and Application
3.7 Global Key Players of Next-Generation Oncology Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Oncology Solution Breakdown Data by Type
4.1 Global Next-Generation Oncology Solution Historic Market Size by Type (2018-2023)
4.2 Global Next-Generation Oncology Solution Forecasted Market Size by Type (2024-2029)
5 Next-Generation Oncology Solution Breakdown Data by Application
5.1 Global Next-Generation Oncology Solution Historic Market Size by Application (2018-2023)
5.2 Global Next-Generation Oncology Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Next-Generation Oncology Solution Market Size (2018-2029)
6.2 North America Next-Generation Oncology Solution Market Size by Type
6.2.1 North America Next-Generation Oncology Solution Market Size by Type (2018-2023)
6.2.2 North America Next-Generation Oncology Solution Market Size by Type (2024-2029)
6.2.3 North America Next-Generation Oncology Solution Market Share by Type (2018-2029)
6.3 North America Next-Generation Oncology Solution Market Size by Application
6.3.1 North America Next-Generation Oncology Solution Market Size by Application (2018-2023)
6.3.2 North America Next-Generation Oncology Solution Market Size by Application (2024-2029)
6.3.3 North America Next-Generation Oncology Solution Market Share by Application (2018-2029)
6.4 North America Next-Generation Oncology Solution Market Size by Country
6.4.1 North America Next-Generation Oncology Solution Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Next-Generation Oncology Solution Market Size by Country (2018-2023)
6.4.3 North America Next-Generation Oncology Solution Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Next-Generation Oncology Solution Market Size (2018-2029)
7.2 Europe Next-Generation Oncology Solution Market Size by Type
7.2.1 Europe Next-Generation Oncology Solution Market Size by Type (2018-2023)
7.2.2 Europe Next-Generation Oncology Solution Market Size by Type (2024-2029)
7.2.3 Europe Next-Generation Oncology Solution Market Share by Type (2018-2029)
7.3 Europe Next-Generation Oncology Solution Market Size by Application
7.3.1 Europe Next-Generation Oncology Solution Market Size by Application (2018-2023)
7.3.2 Europe Next-Generation Oncology Solution Market Size by Application (2024-2029)
7.3.3 Europe Next-Generation Oncology Solution Market Share by Application (2018-2029)
7.4 Europe Next-Generation Oncology Solution Market Size by Country
7.4.1 Europe Next-Generation Oncology Solution Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Next-Generation Oncology Solution Market Size by Country (2018-2023)
7.4.3 Europe Next-Generation Oncology Solution Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Next-Generation Oncology Solution Market Size (2018-2029)
8.2 China Next-Generation Oncology Solution Market Size by Type
8.2.1 China Next-Generation Oncology Solution Market Size by Type (2018-2023)
8.2.2 China Next-Generation Oncology Solution Market Size by Type (2024-2029)
8.2.3 China Next-Generation Oncology Solution Market Share by Type (2018-2029)
8.3 China Next-Generation Oncology Solution Market Size by Application
8.3.1 China Next-Generation Oncology Solution Market Size by Application (2018-2023)
8.3.2 China Next-Generation Oncology Solution Market Size by Application (2024-2029)
8.3.3 China Next-Generation Oncology Solution Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Next-Generation Oncology Solution Market Size (2018-2029)
9.2 Asia Next-Generation Oncology Solution Market Size by Type
9.2.1 Asia Next-Generation Oncology Solution Market Size by Type (2018-2023)
9.2.2 Asia Next-Generation Oncology Solution Market Size by Type (2024-2029)
9.2.3 Asia Next-Generation Oncology Solution Market Share by Type (2018-2029)
9.3 Asia Next-Generation Oncology Solution Market Size by Application
9.3.1 Asia Next-Generation Oncology Solution Market Size by Application (2018-2023)
9.3.2 Asia Next-Generation Oncology Solution Market Size by Application (2024-2029)
9.3.3 Asia Next-Generation Oncology Solution Market Share by Application (2018-2029)
9.4 Asia Next-Generation Oncology Solution Market Size by Region
9.4.1 Asia Next-Generation Oncology Solution Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Next-Generation Oncology Solution Market Size by Region (2018-2023)
9.4.3 Asia Next-Generation Oncology Solution Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Type
10.2.1 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Application
10.3.1 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country
10.4.1 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Next-Generation Oncology Solution Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Next-Generation Oncology Solution Introduction
11.1.4 Illumina Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.1.5 Illumina Recent Developments
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Next-Generation Oncology Solution Introduction
11.2.4 PerkinElmer Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.2.5 PerkinElmer Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Next-Generation Oncology Solution Introduction
11.3.4 Thermo Fisher Scientific Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Roche Holding
11.4.1 Roche Holding Company Details
11.4.2 Roche Holding Business Overview
11.4.3 Roche Holding Next-Generation Oncology Solution Introduction
11.4.4 Roche Holding Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.4.5 Roche Holding Recent Developments
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Next-Generation Oncology Solution Introduction
11.5.4 Agilent Technologies Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.5.5 Agilent Technologies Recent Developments
11.6 Paige
11.6.1 Paige Company Details
11.6.2 Paige Business Overview
11.6.3 Paige Next-Generation Oncology Solution Introduction
11.6.4 Paige Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.6.5 Paige Recent Developments
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Next-Generation Oncology Solution Introduction
11.7.4 GE Healthcare Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.7.5 GE Healthcare Recent Developments
11.8 Varian
11.8.1 Varian Company Details
11.8.2 Varian Business Overview
11.8.3 Varian Next-Generation Oncology Solution Introduction
11.8.4 Varian Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.8.5 Varian Recent Developments
11.9 Brainlab
11.9.1 Brainlab Company Details
11.9.2 Brainlab Business Overview
11.9.3 Brainlab Next-Generation Oncology Solution Introduction
11.9.4 Brainlab Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.9.5 Brainlab Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Next-Generation Oncology Solution Introduction
11.10.4 Qiagen Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.10.5 Qiagen Recent Developments
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic Next-Generation Oncology Solution Introduction
11.11.4 Hologic Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.11.5 Hologic Recent Developments
11.12 Pacific Biosciences
11.12.1 Pacific Biosciences Company Details
11.12.2 Pacific Biosciences Business Overview
11.12.3 Pacific Biosciences Next-Generation Oncology Solution Introduction
11.12.4 Pacific Biosciences Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.12.5 Pacific Biosciences Recent Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Next-Generation Oncology Solution Introduction
11.13.4 AstraZeneca Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.13.5 AstraZeneca Recent Developments
11.14 BGI Group
11.14.1 BGI Group Company Details
11.14.2 BGI Group Business Overview
11.14.3 BGI Group Next-Generation Oncology Solution Introduction
11.14.4 BGI Group Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.14.5 BGI Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Contact US
QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
+1 626 539 9760 / +91 8669986909
ankit@qyresearch.com / enquiry@qyresearch.com
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next-Generation Oncology Solution Market Trends, Opportunities and Forecast 2023-2029| Illumina, PerkinElmer, Thermo Fisher Scientific here
News-ID: 2909986 • Views: …
More Releases from QY Research, Inc.
Through Glass Via (TGV) Interposers Market to Reach US$ 319 Million by 2031, Acc …
Market Summary -
The global market for Through Glass Via (TGV) Interposers was estimated to be worth US$ 101 million in 2024 and is forecast to reach a readjusted size of US$ 319 million by 2031, expanding at a robust CAGR of 18.0% during the forecast period 2025-2031.
According to QY Research, the newly released report titled "Through Glass Via (TGV) Interposers Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031"…
Epinephrine Hydrochloride Injection Market to Reach US$ 5.59 Billion by 2031, Dr …
Market Summary -
The global market for Epinephrine Hydrochloride Injection was estimated to be worth US$ 4,025 million in 2024 and is forecast to reach a readjusted size of US$ 5,592 million by 2031, expanding at a steady CAGR of 4.8% during the forecast period 2025-2031.
According to QY Research, the newly released report titled "Epinephrine Hydrochloride Injection Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven…
Brushless Drone Motor Market to Reach US$ 3.11 Billion by 2031, Driven by Rapid …
Market Summary -
The global market for Brushless Drone Motor was estimated to be worth US$ 1,074 million in 2024 and is forecast to reach a readjusted size of US$ 3,105 million by 2031, expanding at a strong CAGR of 16.7% during the forecast period 2025-2031.
According to QY Research, the newly released report titled "Brushless Drone Motor Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven…
Semiconductor Underfill Market to Reach US$ 1.45 Billion by 2031, Driven by Adva …
Market Summary -
The global market for Semiconductor Underfill was estimated to be worth US$ 721 million in 2024 and is forecast to reach a readjusted size of US$ 1,445 million by 2031, expanding at a robust CAGR of 10.5% during the forecast period 2025-2031.
According to QY Research, the newly released report titled "Semiconductor Underfill Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven assessment of…
More Releases for Oncology
Precision Oncology Market Top Companies Study - Laboratory Corporation of Americ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies)- Market Outlook And Industry Analysis 2031"
The global Precision Oncology market is estimated to reach over USD…
Veterinary Oncology Market Report 2024 - Veterinary Oncology Market Size, Share …
"The Business Research Company recently released a comprehensive report on the Global Veterinary Oncology Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The veterinary oncology market size…
Hepatocellular Carcinoma Pipeline 2024 | Can-Fite BioPharma, Sinocelltech, AVEO …
DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hepatocellular Carcinoma Pipeline…
Oncology Clinical Trials Market: Collaboration and Innovation in Oncology Resear …
Allied Market Research analysts have recently conducted a comprehensive research study titled "Oncology Clinical Trials Market: Global Outlook and Forecast 2023-2030." The report provides detailed information and analysis on key players in the market, including PAREXEL International, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, Novartis, Merck, Bristol Myers Squibb company, and F. Hoffmann-La Roche. The study offers an in-depth analysis that encompasses clear market definitions, classifications, manufacturing processes, cost…
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study…
Oncology Market Size to Hit $447.3 Billion by 2028 | Oncology Industry Forecast …
Market Overview:
According to our experience research team, Oncology Market was valued at USD 283.5 Billion in 2021, and the global Oncology industry is projected to reach a value of USD 447.3 Billion by 2028, at a CAGR of 7.9% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy & Power, Agriculture,…
